Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q2 2024 Earnings Call Transcript August 13, 2024
Zevra Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.48 EPS, expectations were $-0.47.
Operator: Hello, and thank you for joining the Zevra Therapeutics Q2 2024 Financial Results and Corporate Highlights Call. Today’s call is being recorded and will be made available on the company’s website following the conclusion of the call. With that, I will now turn the call over to Nicole...
